These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


463 related items for PubMed ID: 31930767

  • 1. Downregulation of circulating miR 802-5p and miR 194-5p and upregulation of brain MEF2C along breast cancer brain metastasization.
    Sereno M, Haskó J, Molnár K, Medina SJ, Reisz Z, Malhó R, Videira M, Tiszlavicz L, Booth SA, Wilhelm I, Krizbai IA, Brito MA.
    Mol Oncol; 2020 Mar; 14(3):520-538. PubMed ID: 31930767
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Myocyte Enhancer Factor 2C as a New Player in Human Breast Cancer Brain Metastases.
    Galego S, Kauppila LA, Malhó R, Pimentel J, Brito MA.
    Cells; 2021 Feb 12; 10(2):. PubMed ID: 33673112
    [Abstract] [Full Text] [Related]

  • 5. MEF2C and miR-194-5p: New Players in Triple Negative Breast Cancer Tumorigenesis.
    Caetano S, Garcia AR, Figueira I, Brito MA.
    Int J Mol Sci; 2023 Sep 19; 24(18):. PubMed ID: 37762600
    [Abstract] [Full Text] [Related]

  • 6. Comprehensive analysis of differentially expressed long noncoding RNAs, miRNAs and mRNAs in breast cancer brain metastasis.
    An M, Zang X, Wang J, Kang J, Tan X, Fu B.
    Epigenomics; 2021 Jul 19; 13(14):1113-1128. PubMed ID: 34148372
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. CircVCAN promotes glioma progression through the miR-488-3p/MEF2C-JAGGED1 axis.
    Yang S, Gao S, Dong Z.
    Environ Toxicol; 2024 Sep 19; 39(9):4417-4430. PubMed ID: 38842024
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. DNA methylation contributes to deregulation of 12 cancer-associated microRNAs and breast cancer progression.
    Pronina IV, Loginov VI, Burdennyy AM, Fridman MV, Senchenko VN, Kazubskaya TP, Kushlinskii NE, Dmitriev AA, Braga EA.
    Gene; 2017 Mar 10; 604():1-8. PubMed ID: 27998789
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. miRNA expression in breast cancer varies with lymph node metastasis and other clinicopathologic features.
    Wang B, Li J, Sun M, Sun L, Zhang X.
    IUBMB Life; 2014 May 10; 66(5):371-7. PubMed ID: 24846313
    [Abstract] [Full Text] [Related]

  • 14. MiR-135b-5p and MiR-499a-3p Promote Cell Proliferation and Migration in Atherosclerosis by Directly Targeting MEF2C.
    Xu Z, Han Y, Liu J, Jiang F, Hu H, Wang Y, Liu Q, Gong Y, Li X.
    Sci Rep; 2015 Jul 17; 5():12276. PubMed ID: 26184978
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. MiR-374b-5p suppresses RECK expression and promotes gastric cancer cell invasion and metastasis.
    Xie J, Tan ZH, Tang X, Mo MS, Liu YP, Gan RL, Li Y, Zhang L, Li GQ.
    World J Gastroenterol; 2014 Dec 14; 20(46):17439-47. PubMed ID: 25516656
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Identification of microRNA biomarkers in the blood of breast cancer patients based on microRNA profiling.
    Zhang K, Wang YW, Wang YY, Song Y, Zhu J, Si PC, Ma R.
    Gene; 2017 Jul 01; 619():10-20. PubMed ID: 28359916
    [Abstract] [Full Text] [Related]

  • 20. Inhibition of miR-660-5p expression suppresses tumor development and metastasis in human breast cancer.
    Shen Y, Ye YF, Ruan LW, Bao L, Wu MW, Zhou Y.
    Genet Mol Res; 2017 Feb 23; 16(1):. PubMed ID: 28252173
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 24.